Labshake search
Citations for Peprotech :
401 - 450 of 2342 citations for 2R 5S 5 4 amino 5 fluoro 2 oxopyrimidin 1 2H yl 1 3 oxathiolan 2 yl methyl butyrate WXC04778 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: Single bone marrow cell suspensions were plated at 4×106 per well in 2 mL of complete IMDM media supplemented with 150 ng/mL of FLT3L (PeproTech). On day 7 of differentiation ...
-
bioRxiv - Immunology 2024Quote: ... R&D), IL-27 (20 ng/mL, R&D) as well as with 2 μg/mL anti-mouse IL-4 (Peprotech). Alternatively ...
-
bioRxiv - Immunology 2023Quote: ... were cultured in six-well plates (2 ml per well) in complete RPMI 1640 medium + 10% FBS + 10 ng/ml human IL-4 (PeproTech) + 100 ng/ml human GM-CSF (PeproTech) ...
-
bioRxiv - Immunology 2024Quote: ... 50 μM 2-mercaptoethanol) with 100 ng/ml of human FMS-like tyrosine kinase 3 ligand (FLT3L, PeproTech, Cranbury, NJ, USA) for 7 days ...
-
bioRxiv - Immunology 2023Quote: ... the cells were incubated in standard 10% RPMI for Jurkat cells and cytokine enriched 10% RPMI (5 ng/ml IL7 and 5 ng/ml IL15, both from Peprotech) for primary T cells for the duration of experiment ...
-
bioRxiv - Immunology 2020Quote: ... then resuspended at 2 x 105 cells/mL in media supplemented with 20ng/mL IL-2 (PeproTech). miRNA inhibitors (miRCURY LNA miRNA power inhibitor with or without 5’-FAM ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant human IL-2 (rhIL-2, final concentration of 20 ng/mL; Peprotech, Cat# 200-02-1mg), and 2-mercaptoethanol to a final concentration of 0.05mM (Gibco ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... cells were treated with the recombinant human fibroblast growth factor-2 (rhFGF-2, 10 ng/ml, PeproTech) and the vascular endothelial growth factor (VEGF ...
-
bioRxiv - Bioengineering 2020Quote: ... cells were stimulated with 5 nM EGF (PeproTech) for 5 minutes.
-
bioRxiv - Cancer Biology 2021Quote: ... supplemented with 5 ng/mL of EGF (Peprotech), bovine pituitary extract (Life Technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ng/ml human TGFβ1 (Peprotech, 100-21) and 10 μM SB431542 (Selleckchem ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 5 ng/ml Noggin (Peprotech #120-10C) (= d0) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 5 ng/mL IL3 (Cat # 200-03, Peprotech) and 2 ng/μL rhIFNγ (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... 5 ng/mL IL3 (Cat # 200-03, Peprotech), 10 ng/mL G-CSF (Cat# 300-23 ...
-
bioRxiv - Immunology 2020Quote: ... and 5 ng/mL of GM-CSF (Peprotech) and plated in macrophage plates ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ng/mL FGF2 (Peprotech, CAt: 100-18B), 10 ng/mL 5alpha-Dihydrotestosterone (Sigma ...
-
bioRxiv - Cell Biology 2020Quote: ... and/or 5 nM human β-NGF (Peprotech). Cells were grown in differentiation media for 8 days ...
-
bioRxiv - Cell Biology 2020Quote: ... 5 ng/ml of recombinant TGF-β (Peprotech) was used to treat PS1 cells for 72 hours ...
-
bioRxiv - Immunology 2021Quote: ... and human TGF-β1 (Peprotech, 5 ng/mL) were added ...
-
bioRxiv - Cancer Biology 2021Quote: ... and OWRNA with 5 ng/mL TGFB1 (Peprotech) (Supplemental Table S6) ...
-
bioRxiv - Cell Biology 2024Quote: ... and 5 ng/ml human IL-13 (Peprotech) were supplemented to tuft cell differentiation medium (diff) ...
-
bioRxiv - Molecular Biology 2024Quote: ... 5 ng/ml rmIL-6 (all from Peprotech). Progenitors were transferred to RetroNectin®-coated (Lonza ...
-
bioRxiv - Immunology 2023Quote: ... 5 ng/ml IL-11 (PeproTech, 200-11), 25 ng/ml IGF-1 (R&D Systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5 ng/ml human FLT3L (Peprotech) and 5 ng/ml human IL7 (Peprotech) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 5 ng/mL EGF (Peprotech AF-100-15); 100 ng/mL Noggin (Peprotech 120-10C) ...
-
bioRxiv - Genomics 2022Quote: ... IL-5 (10ng/mL; PeproTech Cat. 215-15), EPO (3U/mL ...
-
bioRxiv - Systems Biology 2023Quote: ... 5 ng/ml EGF (Peprotech, AF-100-15), 35 µg/ml bovine pituitary extract (Gibco ...
-
bioRxiv - Cell Biology 2023Quote: ... 5 ng/ml GM-CSF (Peprotech, 315-03) 20% FBS ...
-
Single-cell transcription mapping of murine and human mammary organoids responses to female hormonesbioRxiv - Developmental Biology 2023Quote: ... 5 ng/mL EGF (Peprotech, AF-100–15), 100 ng/mL Noggin (Peprotech ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 ng/mL EGF (PeproTech, Cranbury, NJ, USA), 5 μM A83-01 (Tocris Bioscience) ...
-
bioRxiv - Genomics 2024Quote: ... 5 ng/ml rmIL-7 (Peprotech, #217-17), 10 ng/ml rmSCF (SCF was added only for the first week of culture ...
-
bioRxiv - Neuroscience 2024Quote: ... and 5 ng/ml TPO (PeproTech, 300-18). To induce myeloid lineage producing progenitors ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 μM Y-27632 (PeproTech, Cranbury, NJ, USA) was added to culture media for the first three days of culture ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 ng/mL recombinant human FGF-7 (PeproTech), 37.5 ng/mL recombinant human Heregulin Beta-1 (PeproTech) ...
-
bioRxiv - Immunology 2024Quote: ... 5 ng/mL Interleukin-7 (Peprotech, 200-07), and 5 ng/mL Interleukin-15 (Peprotech ...
-
bioRxiv - Neuroscience 2024Quote: 5 cytokines: 100 ng/mL IL-34 (Peprotech), 50 ng/mL TGF-β1 (Millitenyi Biotech) ...
-
bioRxiv - Bioengineering 2024Quote: ... and 5 nM VEGF 165 Human Recombinant (PeproTech) and was replaced with fresh medium every 48 to −72 h.
-
bioRxiv - Genetics 2024Quote: ... 5 ng/ml recombinant human IL-7 (Peprotech) and 5 ng/ml recombinant human IL-15 (R&D Systems) ...
-
bioRxiv - Cell Biology 2024Quote: ... FGF-7 (5 ng/ml, Peprotech, 100-19), FGF-10 (20 ng/ml ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/ml HGF Protein (PeproTech, 315-23), 10 ng/ml NT-3 Protein (PeproTech ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 ng/ml human EGF (PeproTech, London, UK), 50 µg/ml Primocin (InvivoGen ...
-
bioRxiv - Immunology 2021Quote: ... Cells were cultured at 1×106 cells/ml in complete RPMI-1640 supplemented with 20 ng/ml GM-CSF and 5 ng/ml IL-4 (PeproTech, Cranbury, NJ) for 7 days (Replaced 70% of medium on Day 2 and Day 5) ...
-
bioRxiv - Systems Biology 2020Quote: ... on Day 1 we changed the medium to RPMI + 2% B-27 (minus insulin) + 5ng/ml BMP4 (Peprotech, cat. AF-120-05ET) + 1uM Chiron 99021 and incubated these cells for 48 hours ...
-
bioRxiv - Immunology 2024Quote: ... cells were isolated from bone marrow of C57Bl/6 mice and cultured with granulocyte-macrophage stimulating factor (100ng or 2×103 units per 3×106 cells, Peprotech, Cranbury, NJ) in RPMI-1640 media containing 10% heat inactivated fetal bovine serum ...
-
bioRxiv - Cell Biology 2024Quote: ... Monocytes were differentiated into primary human osteoclasts over 10 days, with media refreshed every 2-3 days and receptor activated nuclear factor κB ligand (RANKL, 25 ng/µL (PeproTech, London, UK) added on differentiation day 8 to stimulate osteoclast formation.
-
bioRxiv - Neuroscience 2022Quote: ... then 4 million cells were seeded per well in 2 ml of EB Medium: complete mTeSR + 0.05 ug/ml BMP-4 (PeproTech, #120-05) + 0.05 ug/ml VEGF (PeproTech ...
-
bioRxiv - Cancer Biology 2022Quote: ... PBMCs were harvested from K3EDTA anti-coagulated whole blood by density gradient centrifugation with Lymphoprep and plated in 12 well plates at 2-4 × 106 cells per well in 10% RPMI + 10 ng/mL human CSF (300-25, Peprotech, UK). Medium was replaced every 2-3 days until adherent populations of macrophages had established ...
-
bioRxiv - Immunology 2024Quote: ... Transduced cells were incubated for 4 days with plate-bound anti-CD3/anti-CD28 in media supplemented with hIL-2 (0.0344 units/mL, Peprotech #200-02). Transduction efficiency was assessed for each experiment by flow cytometry.
-
bioRxiv - Cell Biology 2021Quote: ... composed of complete A-RPMI supplemented with 2 μM Retinoic acid (Stemgent) and Fibroblast growth factor 2 (Peprotech). IMCs were cultivated for 7 days in complete A-RPMI to obtain PTC ...
-
bioRxiv - Immunology 2024Quote: ... interleukin 2 (IL-2) at 100 UI/mL and interleukin 12 (IL-12) at 20 ng/mL (PeproTech) were added to the PBMCs monoculture during the last 24h of the stimulation protocol.